Sci Simple

New Science Research Articles Everyday

# Biology # Bioengineering

Polyketides: Nature's Tiny Warriors in Medicine

Exploring polyketides and their role in creating new medicines.

Wenzheng Jin, Jiaming Tu, Bei Zhang, Xuri Wu, Yijun Chen

― 6 min read


Engineering Polyketides Engineering Polyketides for Medicine compounds from polyketides. Innovative methods create new medicinal
Table of Contents

Polyketides are a group of natural compounds that are produced by tiny organisms like bacteria and fungi. They are famous for their wide range of structures and uses, especially in medicine. Some polyketides have properties that can fight cancer or bacteria. Think of them as nature’s little warriors, battling diseases while hanging out in the microscopic world.

What Makes Polyketides Special?

One reason polyketides are so interesting is that they come in many shapes and sizes. This diversity is like having a box of assorted chocolates — each one is unique, but they all come from a similar recipe. The process of making polyketides involves special enzymes known as polyketide synthases (PKSs). These enzymes act like assembly lines in a factory, producing various polyketides based on specific instructions.

The Machinery Behind PKS

PKSs can be divided into different types based on how they operate. Type I PKSs, for example, work in a modular way. Imagine a Lego set where each piece represents a specific function in the synthesis of polyketides. These units are put together in a specific order to make the final product. Since researchers began to study these assembly lines, a concept has emerged that likens this process to building with Lego bricks.

Researchers are now figuring out how to rearrange these building blocks to create new polyketides, much like creating a new structure with Legos that aren’t in the original set. This has led to the ability to design polyketides with specific properties, increasing their usefulness in medicine.

Challenges in Engineering PKS

While it sounds like a dream to create new polyketides through engineering, it’s not all rainbows and sunshine. The complex shapes and mobile parts of PKSs can make them tricky to work with. Even after making a change, the assembly line can become fragile and stop working properly, much like a LEGO structure that falls apart if you take out a crucial piece.

Learning from Evolution

To tackle these challenges, scientists have started looking at how these enzymes have evolved over time. By studying the changes that have happened naturally in PKS over generations, they can come up with new tricks to improve these enzymes in the lab. For example, when genes are swapped or modified naturally between similar modules in the PKSs, it opens up new possibilities for creating variations of polyketides.

In one study, researchers discovered that certain sections of the PKS genes showed almost identical sequences across different modules. They named these sections "ATconversion" regions because they were specific to the acyltransferase (AT) part of the synthase, which plays a key role in determining the type of building blocks used in polyketide synthesis. This discovery sparked the idea of using these recognizable ATconversion regions for engineering new polyketides.

Finding New Candidates

By harnessing the idea of gene swaps, researchers have been able to spot similar Biosynthetic Gene Clusters in different bacteria. It’s like going through your friend’s toy box and finding similar pieces to your own LEGO set. In one case, a new biosynthetic gene cluster was found in a bacterium known as S. mangrovisoli. This cluster was similar to one that made a polyketide called cinnamomycin, which has shown anti-cancer properties.

Making New Polyketides

With the exciting discovery of new gene clusters, researchers embarked on a mission to combine genes from different sources. By swapping sections of the cmm cluster (the one that makes cinnamomycin) with sections from the newly discovered mgm cluster, they successfully created polyketide variants, also known as mangromycins. This is like mixing two different LEGO sets together to create something entirely novel!

The Engineering Process

The engineering process involved carefully replacing the ATconversion regions of the genes. Some of these changes led to the production of new compounds that had similar properties to cinnamomycin but with unique characteristics. It’s like adding a special ingredient to a recipe that makes the final dish even tastier.

Success and Surprises

After conducting numerous experiments, the researchers found that the variations of mangromycins produced were not only new but also efficient. Some of these new compounds were even produced in greater quantities than the original cinnamomycins. It was as if they had stumbled upon a secret recipe that made the sweets even sweeter!

Fine-Tuning Production

As researchers continued to explore the potential of these polyketides, they discovered that subtle changes to the enzymes involved could lead to different outcomes in the products made. This is akin to a chef who knows that adding a pinch of salt or a dash of pepper can change the flavor of a dish dramatically. Such fine-tuning in the lab allows for targeted production of diverse polyketides, making it possible to cater to various medicinal needs.

The Role of Proofreading

An interesting finding during this research was the role of certain domains (parts) of the PKS that acted like proofreaders during the polyketide production process. These proofreading elements ensure that the correct building blocks get incorporated into the final product. Imagine having a friend who double-checks your LEGO assembly to ensure you place the right pieces in the right spots — this is vital for producing polyketides accurately.

The Active Site Cap

Researchers also identified a specific region in the PKS, called the "Active Site Cap," that plays a significant role in determining the type of building blocks used. By manipulating this area, they could influence which polyketide was produced. It’s like changing the nozzle of a frosting bag to create different designs on a cake!

Final Steps to Polyketide Production

After successfully creating polyketide variants, the researchers moved on to the final steps to create a new polyketide called mangromycin C. This process involved modifying an existing gene to prevent unwanted chemical changes during the synthesis. The team orchestrated various genetic changes across multiple fermentation rounds to optimize the production of this new compound.

The Bigger Picture

The success of these engineering efforts represents a significant step forward in the field of natural product discovery. With the knowledge gained from evolutionary processes and the application of engineering techniques, researchers can now access natural compounds in ways not previously possible. It’s like turning on a new faucet that releases a flow of exciting and beneficial compounds!

Conclusion: A Promising Future

The exploration of polyketides and the methods developed to engineer their production highlight just how innovative and resourceful scientists can be. By combining the wisdom of nature with technological advancements, we are unlocking a treasure trove of possibilities for new medicines and treatments. So, the next time you take a medicine that helps you feel better, think about the tiny warriors, the polyketides, and the creative science behind their production—because a whole lot of LEGO-style building and some clever rearranging may have brought that remedy to your medicine cabinet!

Original Source

Title: Gene Conversion Directed Successive Engineering of Modular Polyketide Synthases

Abstract: Modular polyketide synthases (PKSs) can produce various secondary metabolites in a collinearity fashion. Although rational engineering of modular PKS can ultimately create a diverse array of novel compounds, de novo generation of defined structures usually results in the loss or remarkable decline of productivity due primarily to the incompatibility of different elements. Here, we present a modular PKS engineering strategy driven by an evolutionary event of gene conversion to accomplish successive engineering of the modular PKS in cinnamomycin biosynthetic gene cluster (cmm BGC). By simulating the gene conversion process, cmm BGC is consecutively reprogrammed to generate a novel macrolide with predicted structural features. Moreover, in contrast to previous notion, the intra-module KS domain is demonstrated to associate with the selectivity of extender units. Collectively, the coordination between evolutionary consequence and functional manipulation of assembly line may shed a new light on modular PKS engineering. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=104 SRC="FIGDIR/small/630704v1_ufig1.gif" ALT="Figure 1"> View larger version (17K): [email protected]@[email protected]@13f6fa6_HPS_FORMAT_FIGEXP M_FIG Gene conversion process, typically occurred in KS (purple squares) and AT (blue squares), plays an integral role of structural diversity of polyketides. In this study, an unusual gene conversion was observed in cmm BGC. Subsequently, a homologous BGC was obtained through genome mining by a gene conversion-associated KS domain. Under the direction of gene conversion, the modular PKS in cmm BGC was successively reprogrammed, resulting in de novo biosynthesis of a new-to-nature polyketide. C_FIG

Authors: Wenzheng Jin, Jiaming Tu, Bei Zhang, Xuri Wu, Yijun Chen

Last Update: 2024-12-30 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.12.29.630704

Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.29.630704.full.pdf

Licence: https://creativecommons.org/licenses/by-nc/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles